Dynavax Technologies Corp (DVAX)

Überblick Nachrichten Preisverlauf Optionskette Financials Forum Prognose Aktiensplit

Schlusskurs vom Vortag:

24-Stunden-Volumen:

Relative Volume:

Marktkapitalisierung:

Nettoeinkommen (Verlust:

Netto-Cashflow:

1W Leistung:

1M Leistung:

6M Leistung:

1J Leistung:

1-Tages-Spanne:

1-Wochen-Bereich:

52-Wochen-Spanne:

Dynavax Technologies Corp Stock (DVAX) Company Profile

Dynavax Technologies Corp

Healthcare (1113)

(510) 848-5100

2100 POWELL STREET, EMERYVILLE, CA

@DynavaxCorp

Nächster Verdiensttermin

Neueste SEC-Einreichungen

DVAX's Discussions on Twitter

Vergleichen Sie DVAX mit anderen Aktien

Aktien	Preis	Marktkapitalisierung	Umsatz	Nettogewinn	Free Cashflow	ENV
DVAX Dynavax Technologies Corp	15.48	1.76B	260.81M	20.48M	22.67M	0.13
ZTS Zoetis Inc	124.96	54.61B	9.40B	2.65B	2.24B	5.935
TAK Takeda Pharmaceutical Co Adr	16.91	52.47B	29.63B	260.53M	5.51B	0.0788
HLN Haleon Plc Adr	10.42	46.18B	14.26B	1.98B	2.47B	0.4327
TEVA Teva Pharmaceutical Industries Ltd Adr	32.53	36.87B	16.88B	666.71M	251.19M	0.6132
UTHR United Therapeutics Corp	476.78	20.38B	3.08B	1.24B	1.07B	25.61

Dynavax Technologies Corp Stock (DVAX) Upgrades & Downgrades

Datum	Aktion	Analytiker	Ratingänderung
2025-02-11	Herabstufung	Goldman	Neutral → Sell
2024-02-01	Eingeleitet	Goldman	Neutral
2022-09-27	Eingeleitet	JMP Securities	Mkt Outperform
2022-01-06	Fortgesetzt	Goldman	Buy
2021-08-06	Eingeleitet	Goldman	Buy
2020-08-07	Bestätigt	H.C. Wainwright	Buy
2020-08-03	Bestätigt	H.C. Wainwright	Buy
2020-06-15	Eingeleitet	Evercore ISI	Outperform
2019-10-18	Eingeleitet	H.C. Wainwright	Buy
2019-07-11	Hochstufung	Cantor Fitzgerald	Neutral → Overweight
2019-02-27	Bestätigt	Cantor Fitzgerald	Overweight
2018-05-10	Hochstufung	JP Morgan	Neutral → Overweight
2018-03-08	Bestätigt	Cantor Fitzgerald	Overweight
2018-02-14	Herabstufung	JP Morgan	Overweight → Neutral
2017-09-25	Bestätigt	RBC Capital Mkts	Outperform
2017-09-15	Eingeleitet	Cantor Fitzgerald	Overweight
2017-07-31	Hochstufung	JP Morgan	Neutral → Overweight
2017-07-31	Hochstufung	RBC Capital Mkts	Sector Perform → Outperform
2017-05-09	Bestätigt	RBC Capital Mkts	Sector Perform
2016-04-28	Herabstufung	RBC Capital Mkts	Outperform → Sector Perform
2016-04-27	Herabstufung	JP Morgan	Overweight → Neutral
2015-11-30	Eingeleitet	RBC Capital Mkts	Outperform
2013-11-25	Hochstufung	MLV & Co	Hold → Buy
2013-02-25	Herabstufung	MLV & Co	Buy → Hold
2012-11-16	Bestätigt	MLV & Co	Buy

Alle ansehen

Dynavax Technologies Corp Aktie (DVAX) Neueste Nachrichten

Finanzdaten der Dynavax Technologies Corp-Aktie (DVAX)

Dynavax Technologies Corp (DVAX)

Dynavax Technologies Corp Stock (DVAX) Company Profile

Vergleichen Sie DVAX mit anderen Aktien

Dynavax Technologies Corp Stock (DVAX) Upgrades & Downgrades

Dynavax Technologies Corp Aktie (DVAX) Neueste Nachrichten

Signal Recap: Does Dynavax Technologies Corporation stock have upside surprise potentialJuly 2025 Gainers & AI Driven Stock Movement Reports - baoquankhu1.vn

Dynavax president Novack sells $1.78m in shares - Investing.com

Dynavax CEO ignored last-minute suitor's email after signing $2.2 billion Sanofi deal - The Business Journals

Dynavax Technologies (NASDAQ:DVAX) Stock Passes Above 200 Day Moving AverageTime to Sell? - MarketBeat

Jim Cramer Highlights Sanofi's Bid for Dynavax - Finviz

Jim Cramer Highlights Sanofi’s Bid for Dynavax - Insider Monkey

Dynavax Technologies Corporation (DVAX) Investor Outlook: Exploring a 30.74% Potential Upside - DirectorsTalk Interviews

Dynavax (DVAX) Shares Rise 1.9% as New Bidder Emerges Post-Sanofi Deal - Intellectia AI

Dynavax Technologies (NASDAQ:DVAX) Sets New 12-Month HighStill a Buy? - MarketBeat

Dynavax gains on disclosure another bidder interested after deal announced (DVAX:NASDAQ) - Seeking Alpha

Dynavax Technologies stock hits 52-week high at $15.68 - Investing.com

Dynavax Technologies Corporation (NASDAQ:DVAX) Receives Average Rating of “Hold” from Brokerages - Defense World

Is It Time To Reassess Dynavax Technologies (DVAX) After Its Recent Share Price Surge - Yahoo Finance

Will Dynavax Technologies Corporation stock beat EPS estimatesJuly 2025 Outlook & Weekly High Return Opportunities - Улправда

Is Dynavax Technologies Corporation stock ready for breakoutWeekly Profit Recap & High Accuracy Buy Signal Tips - Улправда

How analysts rate Dynavax Technologies Corporation stock todayJuly 2025 Snapshot & Verified Swing Trading Watchlist - ulpravda.ru

Is Dynavax Technologies Corporation (DYF1) stock cheap vs fundamentalsWeekly Trade Analysis & Community Driven Trade Alerts - ulpravda.ru

What risks investors should watch in Dynavax Technologies Corporation stockJuly 2025 Chart Watch & High Accuracy Trade Alerts - Улправда

Dynavax Technologies CorporationCommon Stock (NQ: DVAX - FinancialContent

Sanofi $2.2 billion vaccine deal comes alongside FDA setback - MSN

DVAX Stock Price, Forecast & Analysis | DYNAVAX TECHNOLOGIES CORP (NASDAQ:DVAX) - Chartmill

Halper Sadeh LLC Encourages DVAX, FONR, DBRG, ONTF Shareholders to Contact the Firm to Discuss Their Rights - FinancialContent

$HAREHOLDER ALERT: The M&A Class Action Firm Is Investigating the Merger—DVAX, FONR, DBRG, and ONTF - GlobeNewswire Inc.

Halper Sadeh LLC Encourages DBRG, FOLD, DVAX Shareholders to Contact the Firm to Discuss Their Rights - Finviz

Dynavax Technologies Corporation (NASDAQ:DVAX) Surges 42% Yet Its Low P/S Is No Reason For Excitement - simplywall.st

Why Dynavax stock soared today - MSN

$HAREHOLDER ALERT: The M&A Class Action Firm Announces An Investigation of Dynavax Technologies Corporation (NASDAQ - MarketScreener

Evaluating Dynavax (DVAX) After Its Recent Share Price Rally: Is the Stock Still Undervalued? - simplywall.st

Pacer Advisors Inc. Grows Holdings in Dynavax Technologies Corporation $DVAX - MarketBeat

Dynavax Investor Alert: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Dynavax Technologies CorporationDVAX - The Malaysian Reserve

Sanofi Acquires Emeryville's Dynavax Technologies for $2.2 Billion, Bolstering Vaccine Portfolio Amid Industry Optimism - Hoodline

Sanofi adds HBV vaccine, shingles candidate via Dynavax takeout: Deals Report - BioCentury

CORRECTING and REPLACING Dynavax Investor Alert: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Dynavax Technologies CorporationDVAX - Business Wire

Dynavax Technologies (DVAX) Investor Outlook: Analyzing a 33% Potential Upside in the Biopharma Sector - DirectorsTalk Interviews

Dynavax (DVAX) rockets 38% on Sanofi $2-billion merger - MSN

Insider Selling: Dynavax Technologies (NASDAQ:DVAX) COO Sells 30,000 Shares of Stock - MarketBeat

Dynavax Technologies (NASDAQ:DVAX) Sees Large Volume IncreaseShould You Buy? - MarketBeat

Emeryville's Dynavax accepts $2.2 billion buyout from Sanofi following year of investor pressure - The Business Journals

Dynavax Technologies Signs Agreement and Plan of Merger With Sanofi - TradingView — Track All Markets

Sanofi Agrees to Buy Dynavax for $2.2 Billion After FDA MS Drug Rejection - GuruFocus

Small Cap Stocks To Keep An Eye OnDecember 25th - MarketBeat

Sanofi (SNY) to Acquire Dynavax Technologies Corporation (DVAX) - Insider Monkey

Sanofi pushes ahead on adult vaccines with $2.2 billion Dynavax deal - MSN

Exchange Traded Concepts LLC Has $2 Million Stake in Dynavax Technologies Corporation $DVAX - MarketBeat

Dynavax Technologies (NASDAQ:DVAX) Stock Rating Upgraded by Wall Street Zen - MarketBeat

Small Cap Stocks To Follow TodayDecember 24th - MarketBeat

Biggest stock movers Wednesday: DVAX, NKE, INTC, and more - MSN

Stock Market Today: Dow Jones, S&P 500 Futures Slip After Christmas Day—Nvidia, Sobr Safe, Biohaven In Focus - Sahm

Nvidia, Sobr Safe And 3 Stocks To Watch Heading Into Friday - Benzinga

Dynavax (DVAX) Rockets 38% on Sanofi $2-Billion Merger - Insider Monkey

Assessing Dynavax After a 42% Surge and Strong HEPLISAV B Growth in 2025 - Yahoo Finance

Finanzdaten der Dynavax Technologies Corp-Aktie (DVAX)

Umsatz

Nettogewinn

Free Cashflow

ENV

Ähnlich wie DVAX